PI 3-Kinase Signaling Pathways in Disease

The PI3K-Akt-mTOR signaling pathway is one of the primary mechanisms for controlling cell growth, survival, and motility in response to intracellular signaling and extracellular cues. This meeting brings together scientists and clinicians from academia and industry to discuss the opportunities and liabilities of targeting the PI3K- and related pathways in disease, drawing on human pathophysiology and genetics, preclinical models and clinical data with PI3K pathway inhibitors. A joint meeting on Integrating Metabolism and Tumor Biology will enhance opportunities for interdisciplinary interactions.
+ show speakers and program
cell biology, cancer, signaling, biochemistry, drug discovery, immunology

13 Jan - 18 Jan 2015
Vancouver
Canada
meeting website